News

April 27th 2018 Completion of 500 million JPY Series B financing

TAGCyx Biotechnologies Inc. (Tokyo, Japan) has raised 500 million JPY in Series B financing as of 24th April 2018, from four venture capital firms, the University of Tokyo Edge Capital Co., Ltd. (UTEC) (Tokyo), SMBC Venture Capital Co., Ltd. (Tokyo), UTokyo Innovation Platform Co., Ltd. (Tokyo) and Mizuho Capital Co., Ltd. (Tokyo).

20180427  Press Release(Eng)

Comments are closed.